REAL-WORLD COMPARATIVE STUDY OF THE EFFECTIVENESS, SAFETY, AND HEALTH CARE RESOURCE UTILIZATION (HCRU) OF LISOCABTAGENE MARALEUCEL AND BISPECIFICS IN THIRD-LINE OR LATER LARGE B-CELL LYMPHOMA (LBCL)

EHA Library, Narendranath Epperla, 4207973

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT AS CONSOLIDATION AFTER CD3XCD20 BISPECIFIC ANTIBODIES IN RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMAS: AN LWP-CTIWP STUDY ON 52 CASES FROM THE EBMT REGISTRY

EHA Library, Federico Erbella, 4207974

PRIMARY ANALYSIS OF THE POLATUZUMAB VEDOTIN PLUS R-CHP (POLA-R-CHP) COHORT OF FIL-MAB, A PROSPECTIVE, MULTICENTER ITALIAN MULTICOHORT REAL-LIFE STUDY

EHA Library, Marco Ladetto, 4207975

DENOSUMAB VERSUS ALENDRONATE FOR PREVENTING STEROID-INDUCED OSTEOPOROSIS IN MALIGNANT LYMPHOMA: A MULTICENTER PHASE III TRIAL

EHA Library, Shohei Kikuchi, 4207976

A FULLY OBJECTIVE 3‑VARIABLE PROGNOSTIC SCORE FOR DIFFUSE LARGE B‑CELL LYMPHOMA: DEVELOPMENT AND EXTERNAL VALIDATION IN TWO INDEPENDENT COHORTS TOTALING 776 PATIENTS

EHA Library, Yoshimasa Kamoda, 4207977

INTRODUCTION OF CAR-T CELL THERAPY DRAMATICALLY IMPROVED OUTCOMES OF PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA RECEIVING SECOND-LINE TREATMENT AT A POPULATION LEVEL

EHA Library, Prokop Vodicka, 4207978

LARGE-SCALE REAL-WORLD CLINICAL CHARACTERISTICS AND EFFICACY OF DIFFUSE LARGE B-CELL LYMPHOMA ACROSS DISTINCT MOLECULAR SUBTYPES: INTERIM DATA FROM THE BELIEVE STUDY

EHA Library, Pengpeng Xu, 4207979

RE‑EVALUATING THE ROLE OF AUTOLOGOUS STEM CELL TRANSPLANTATION IN PRIMARY CNS DIFFUSE LARGE B‑CELL LYMPHOMA IN THE TARGETED‑THERAPY ERA: A PROPENSITY SCORE–MATCHED MULTICENTER REAL‑WORLD STUDY

EHA Library, Mengyuan Liu, 4207980

R-GEMOX+NIVOLUMAB VS R-GEMOX AS 2ND-LINE THERAPY FOR LARGE B-CELL LYMPHOMA IN TRANSPLANT-INELIGIBLE PATIENTS: FINAL ANALYSIS OF THE NIVEAU TRIAL, A PHASE 3 STUDY OF THE AGMT, GLA, HOVON, LYSA AND PLRG

EHA Library, Gerhard Held, 4207981

POLATUZUMAB-BR VS TAFASITAMAB-LENALIDOMIDE IN RELAPSED/REFRACTORY DLBCL: A PROPENSITY SCORE–MATCHED ANALYSIS FROM THE POLISH LYMPHOMA RESEARCH GROUP (PLRG)

EHA Library, Magdalena Olszewska-Szopa, 4207982

COMPARATIVE REAL‑WORLD OVERALL SURVIVAL IN DIFFUSE LARGE B‑CELL LYMPHOMA: CAR T‑CELL THERAPIES VERSUS BISPECIFIC ANTIBODIES

EHA Library, Vladimir Otasevic, 4207983

FEASIBILITY AND SAFETY OF RAPID GLOFITAMAB RAMP-UP FOR THE TREATMENT OF RELAPSED AND REFRACTORY LARGE B-CELL LYMPHOMA

EHA Library, Celine Liem, 4207984

OUTCOME OF NEWLY DIAGNOSED AGGRESSIVE B-CELL LYMPHOMA WITH CONCURRENT INDOLENT LYMPHOMA: A POOLED POST-HOC ANALYSIS OF FOUR PROSPECTIVE PHASE III DSHNHL/GLA TRIALS

EHA Library, Konstantinos Christofyllakis, 4207985

DEVELOPMENT AND EXTERNAL VALIDATION OF A SIMPLE PROGNOSTIC INDEX FOR PRIMARY MEDIASTINAL B-CELL LYMPHOMA: PMBCL-PI

EHA Library, Oguzhan Koca, 4207986

RISK FACTORS FOR EARLY DEATH AND POOR SURVIVAL IN HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AS AN ONSET OF DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Hongyan Tong, 4207987

MENINGEAL STROMAL NICHE REWIRES THYMIDYLATE SYNTHESIS AND THYMIDINE SALVAGE IN METHOTREXATE-RESISTANT CENTRAL NERVOUS SYSTEM ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Shirley Lam, 4207988

A DIETARY PAN-AMINO ACID DEPRIVATION SCREEN IN VIVO REVEALS A CRITICAL ROLE FOR HISTIDINE IN T-ALL

EHA Library, Komal Mandleywala, 4207989

PH+B-ALL IS DEFINED BY BCR::ABL1-INDUCED ENHANCER REPROGRAMMING AND HYPERSENSITIVITY TO ENHANCER-TARGETING DRUGS

EHA Library, Niklas Feldhahn, 4207990

LIPIDOMIC REPROGRAMMING LINKS VEGF-DEPENDENT CNS ADAPTATION TO FERROPTOSIS SENSITIVITY IN ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Vera Muench, 4207991

IKZF1 LOSS ESTABLISHES A SELF-RENEWING THYMOCYTE POOL DRIVING T-ALL

EHA Library, Maaike Van Trimpont, 4207992

MULTICENTER VALIDATION OF AN OPEN ACADEMIC PROTOCOL FOR NGS-BASED DETECTION OF MEASURABLE RESIDUAL DISEASE (MRD) IN ACUTE LYMPHOBLASTIC LEUKEMIA: A JOINT EUROCLONALITY-NGS AND EUROMRD STUDY

EHA Library, Eva Fronkova, 4207993

IN VIVO ISOGENIC MODELLING UNCOVERS TP53-ASSOCIATED RELAPSE TRAJECTORIES IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Stephanie Gachet, 4207994

DOWN SYNDROME FETAL LIVER HAEMATOPOIETIC STEM AND PROGENITOR CELLS FAIL TO PROVIDE A PERMISSIVE CELL CONTEXT FOR KMT2A::AFF1 INFANT ALL INITIATION

EHA Library, Lucy Hamer, 4207995

MENIN INHIBITION SENSITIZES KMT2A-REARRANGED B-ALL TO FERROPTOSIS THROUGH SLC7A11 DOWNREGULATION

EHA Library, Martina Maria Capelletti, 4207996

SMARCA4 MUTATIONS PROMOTE CHEMOTHERAPY RESISTANCE IN T-ACUTE LYMPHOBLASTIC LEUKEMIA THROUGH ALTERED  CHROMATIN REMODELING

EHA Library, Violeta García-Hernández, 4207997

LONGITUDINAL IMMUNE REMODELING IN ADULT PH+ ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS TREATED WITH FRONTLINE PONATINIB AND BLINATUMOMAB

EHA Library, Nadia Peragine, 4207998

A TARGETABLE, TWO-LEVEL POSITIVE FEEDBACK LOOP REGULATES MYC ONCOGENE EXPRESSION IN SIGNALING-INDUCED LEUKEMIA

EHA Library, Niklas Feldhahn, 4207999

A NOVEL INTRONIC ENHANCER REGULATES BCR::ABL1 EXPRESSION IN PHILADELPHIA CHROMOSOME–POSITIVE B-ALL AND CML

EHA Library, Jintao Zhu, 4208000

SERTRALINE MODULATES CHOLESTEROL METABOLISM AND SYNERGIZES WITH PROTEASOME AND HDAC INHIBITORS TO TARGET SERINE/GLYCINE METABOLIC ADDICTION IN T-CELL MALIGNANCIES

EHA Library, Anaís Sánchez-Castillo, 4208001

REVEALING THERAPEUTIC VULNERABILITY IN HIGHLY CHEMORESISTANT TCF3::HLF B-ALL: GENOME-WIDE CRISPR/CAS9 SCREENING IDENTIFIES CRITICAL MOLECULAR DETERMINANTS OF RESPONSE TO THE NEW PRODRUG ACHM-025

EHA Library, Zahra Sheybani, 4208002

TARGETING HMOX1 EXPLOITS A FERROPTOSIS VULNERABILITY IN HIGH-RISK ETP-ALL

EHA Library, Martina Portaluri, 4208003

EPITP - AN EPIGENETIC BIOMARKER OF EARLY T-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Fernanda Schäfer Hackenhaar, 4208005

BCG MOBILIZES SYSTEMIC IMMUNITY TO RESTRAIN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Mina NF Morcos, 4208006

COOPERATIVITY OF KMT2A-MLLT1 WITH KMT2C LOSS ENABLES DUAL MYELOID-LYMPHOID LEUKEMIC POTENTIAL AND INDUCES CYTOSKELETAL REPROGRAMMING IN A ZEBRAFISH MODEL OF INFANT LEUKEMIA

EHA Library, Sarada Ketharnathan, 4208007

METABOLIC REPROGRAMMING TOWARD OXIDATIVE PHOSPHORYLATION DRIVES RESISTANCE IN B-ALL

EHA Library, Maximilian Mönnig, 4208008

NEXT-GENERATION FLT3-DIRECTED CHIMERIC ANTIGEN RECEPTOR T CELL (FLT3CART) IMMUNOTHERAPY FOR KMT2A-REARRANGED ACUTE LYMPHOBLASTIC LEUKEMIA (KMT2A-R ALL)

EHA Library, Shubhmita Bhatnagar, 4208009

VENETOCLAX-BASED COMBINATIONS TARGET HIGH-RISK ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: SYNERGISTIC ACTIVITY WITH PONATINIB AND BLINATUMOMAB ACROSS MOLECULAR SUBGROUPS

EHA Library, Federico Lo Schiavo, 4208010

FLT3 AND BCL2 AS THERAPEUTIC TARGETS IN PAX5-ALTERED PEDIATRIC B-CELL PRECURSOR LYMPHOBLASTIC LEUKEMIA

EHA Library, Alessia Curto, 4208011

TARGETABLE, RELAPSE SPECIFIC MUTATIONS ARE SIGNIFICANTLY ENRICHED IN  ACUTE LYMPHOBLASTIC LEUKEMIA DURING INDUCTION THERAPY AND CAN ATTAIN CLONAL DOMINANCE

EHA Library, Rabab Allawati, 4208012

DIVERGENCE BETWEEN LEUKEMOGENIC BASAL T-CELL RECEPTOR SIGNALING AND ANTIGEN-INDUCED ACTIVATION IN MOUSE MODELS OF T-LYMPHOBLASTIC LEUKEMIA/LYMPHOMA

EHA Library, Marina Baessa, 4208013

SINGLE-CELL ANALYSIS REVEALS DISTINCT CLONAL ORIGINS OF CML-LIKE AND TYPICAL BCR::ABL1-POSITIVE ALL

EHA Library, Lenka Hovorkova, 4208014

MYC/BCL2-REARRANGED B-CELL NEOPLASMS WITH PRECURSOR FEATURES: INTEGRATED MOLECULAR PROFILING FOR IMPROVED DIAGNOSTIC CLASSIFICATION

EHA Library, Cecilia Bozzetti, 4208015

T-MAPS: NOVEL SURFACE MARKERS FOR MEASURABLE RESIDUAL DISEASE MONITORING IN PEDIATRIC T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Adela Vavrova, 4208016

EFFICACY OF BIOMIMETIC NANODRUG CX4945 IN B-ALL PATIENT-DERIVED XENOGRAFT MOUSE MODEL

EHA Library, Zheng Ge, 4208017

SHORT PEPTIDE INHIBITORS AGAINST DUX4-R LEUKEMIA

EHA Library, Mara Salomè, 4208018

IGH::ID4-REARRANGEMENTS ARE THE MOST FREQUENT DRIVER ABERRATIONS OF ADULT PAX5ALT B-ALL AND DEFINE A DISTINCT MOLECULAR ENTITY

EHA Library, Sonja Bendig, 4208019

INFLUENCE OF AGE AND CYTOGENETIC RISK GROUP ON THE PROGNOSTIC EFFECT OF KEY COPY NUMBER ALTERATIONS IN B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA, INSIGHTS FROM THE HARMONY PLATFORM

EHA Library, Anthony Moorman, 4208020

SINGLE-CELL MULTIOMICS CAPTURES THE DYNAMICS OF LINEAGE TRANSDIFFERENTIATION IN PAX5 P80R PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Alyssa Alvaro, 4208021

ETV6::JAK2 FUSION PROMOTES CENTRAL NERVOUS SYSTEM INVASION IN MURINE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Telma Costa, 4208022

PREVALENCE AND IMPACT OF INCIDENTALLY DETECTED GERMLINE VARIANTS IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Borbála Péterffy, 4208023

DEVELOPMENT OF ANTIGEN-SPECIFIC CAR-T CELLS TARGETING LEUKEMIA-INITIATING CELLS IN HUMAN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Serena di Iasio, 4208024

PROTEOMIC EXPLORATION OF LINEAGE-SPECIFIC HDAC3 VULNERABILITIES IN KMT2A-REARRANGED ACUTE LEUKEMIA

EHA Library, Jiaer Wang, 4208025

SAFETY AND PRELIMINARY EFFICACY OF OLVEREMBATINIB (HQP1351) COMBINED WITH LISAFTOCLAX (APG-2575) IN PEDIATRIC PATIENTS WITH RELAPSED/REFRACTORY (R/R PH+ ALL): RESULTS OF A PHASE 1B STUDY

EHA Library, Jingliao Zhang, 4208026

DIFFERENCES IN GENOMIC AND TRANSCRIPTOMIC FEATURES BETWEEN ADULTS WITH NEWLY DIAGNOSED BCR::ABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MULTILINEAGE AND LYMPHOID-ONLY INVOLVEMENT

EHA Library, Zhenzhen Jiang, 4208027

THE APPLICATION AND STUDY OF USING NGS FOR DETECTING IG/TCR GENE REARRANGEMENTS IN BONE MARROW FOR MRD MONITORING IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Yang Li, 4208028

COMBINATION OF VENETOCLAX AND CHEMOTHERAPY IN NEWLY DIAGNOSED ADULT T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: INTERIM ANALYSIS OF A MULTICENTER PROSPECTIVE STUDY

EHA Library, Lijun Peng, 4208029

LATE RELAPSE AND PROGNOSTIC HETEROGENEITY IN ETV6-ALTERED PEDIATRIC B-ALL: A RETROSPECTIVE COHORT STUDY

EHA Library, Xiaoyu Chen, 4208030

A PHASE 2 STUDY OF VENETOCLAX PLUS MINI-HYPER-CVD IN OLDER ADULTS WITH DE NOVO PHILADELPHIA NEGATIVE ALL

EHA Library, Marlise Luskin, 4208031

UPDATED RESULTS OF POLARIS-1 (PART 1), A GLOBAL REGISTRATIONAL PHASE 3 STUDY: OLVEREMBATINIB COMBINED WITH LOW-INTENSITY CHEMOTHERAPY IN NEWLY DIAGNOSED PH+ ALL

EHA Library, Suning Chen, 4208032

EARLY B-CELL RECOVERY AFTER BREXUCABTAGENE AUTOLEUCEL DOES NOT PREDICT INFERIOR EVENT-FREE SURVIVAL IN ADULT B-ALL

EHA Library, Kriti Gera, 4208033

SUBCUTANEOUS BLINATUMOMAB FOR PATIENTS WITH RELAPSED/REFRACTORY PHILADELPHIA CHROMOSOME–POSITIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: RESULTS FROM A PHASE 1/2 STUDY

EHA Library, Elias Jabbour, 4208034

REAL-WORLD EFFICACY AND SAFETY OF INOTUZUMAB OZOGAMICIN IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: A MULTICENTER OK-1 COHORT STUDY

EHA Library, Jiaxin Zheng, 4208035

PHASE I CLINICAL TRIAL OF CD19 CAR -T CELLS SECRETING PD-1-TARGETING IL-21 IN RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Qingyang Liu, 4208036

THE EFFECT OF OBECABTAGENE AUTOLEUCEL ON ADULT PATIENTS WITH RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA AND EXTRAMEDULLARY DISEASE

EHA Library, Jae H. Park, 4208037

COMBINATION THERAPY WITH BLINATUMOMAB AND ASCIMINIB FOR PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: RESULTS FROM A PHASE I/II STUDY

EHA Library, Nicholas Short, 4208038

CD19 CAR-T CELLS FEATURING A CD8Α HINGE GLYCINE DELETION EXHIBIT FAVORABLE SAFETY AND EFFICACY IN R/R ALL

EHA Library, Weiwei Tian, 4208039

EVALUATION OF PATIENT SPECIFIC STRUCTURAL VARIANTS AS MEASURABLE RESIDUAL DISEASE MARKERS IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKAEMIA

EHA Library, Karin Sollander, 4208040

DEEPER REMISSION ACHIEVEMENT AND LONGER LEUKEMIA-FREE SURVIVAL WITH INATI-CEL AS CONSOLIDATION THERAPY IN ALLOGENEIC TRANSPLANT-INELIGIBLE ADOLESCENT AND ADULT PATIENTS WITH B-ALL

EHA Library, Sanfang Tu, 4208041

PHASE II STUDY OF DOSE-ADJUSTED EPOCH ± RITUXIMAB (R) + TAFASITAMAB (TAFA) IN NEWLY-DIAGNOSED (ND) ADULTS WITH PHILADELPHIA CHROMOSOME NEGATIVE (PH-) B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)

EHA Library, Ryan Cassaday, 4208042

LONG-TERM SURVIVAL AND IMMUNOGLOBULIN PATTERNS FOLLOWING BLINATUMOMAB IN INFANTS WITH KMT2A-REARRANGED ALL

EHA Library, Miguel Vieira Martins, 4208043

CLINICAL EFFICACY ANALYSIS OF CAR-T THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY B-ALL WITH CENTRAL NERVOUS SYSTEM  LEUKEMIA

EHA Library, Zhao defeng, 4208044

DONOR AGE ≥50 YEARS COMBINED WITH DONOR-CI ≥3 IDENTIFIES A HIGH-RISK COHORT FOR ADVERSE OUTCOMES AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Yu Wang, 4208045

THE TREATMENT OF B-LYMPHOBLASTIC LYMPHOMA IN THE GERMAN MULTICENTER STUDY GROUP FOR ADULT ALL (GMALL): A RETROSPECTIVE ANALYSIS

EHA Library, Markus Liesenfeld, 4208046

A REAL-WORLD STUDY OF INOTUZUMAB OZOGAMICIN COMBINED WITH VENETOCLAX AS FRONTLINE THERAPY FOR NEWLY-DIAGNOSED PH-NEGATIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS WITH SEVERE COMORBIDITY

EHA Library, Yuchen Yan, 4208047

FATIGUE AND HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH NEWLY DIAGNOSED PH+ ALL TREATED WITH FRONTLINE PONATINIB PLUS BLINATUMOMAB. RESULTS OF THE PHASE III GIMEMA ALL2820 TRIAL

EHA Library, Fabio Efficace, 4208048

EFFICACY AND SAFETY OF  FLUMATINIB COMBINED WITH CHEMOTHERAPY IN NEWLY DIAGNOSED ADULT PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Weimin Wang, 4208049

THE BLINATUMOMAB ERA IN PHILADELPHIA CHROMOSOME POSITIVE B-ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ B-ALL): A SINGLE-CENTER ANALYSIS OF TREATMENT EVOLUTION AND SURVIVAL

EHA Library, Valerie Hui Shan Tan, 4208050

ADJUSTED COMPARISON OF PEDIATRIC AND ADULT TREATMENT REGIMENS IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): RESULTS OF A MAIC ANALYSIS IN A LATIN AMERICAN COHORT

EHA Library, Claudia Valeria Silva Tirado, 4208051

DONOR-DERIVED CAR-T THERAPY FOR RELAPSE OF B-ALL AFTER SECOND ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Zhao defeng, 4208052

PROGNOSIS AND TREATMENT-RELATED TOXICITIES IN DOWN SYNDROME ACUTE LYMPHOBLASTIC LEUKEMIA IN JCCG ALL-B12

EHA Library, Shunsuke Yamamoto, 4208053

MYELOABLATIVE CONDITIONING REGIMENS CONTAINING MELPHALAN OR THIOTEPA IMPROVE SURVIVAL OUTCOMES OF ALLO-HSCT IN CHILDREN WITH RELAPSED ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Zhijie Wei, 4208054

TREATMENT PATTERNS AND OUTCOMES WITH OLUTASIDENIB AFTER VENETOCLAX IN IDH1-MUTATED AML USING REAL-WORLD DATA FROM CHART REVIEW

EHA Library, Pinkal Desai, 4208055

IMPACT OF MRD AND BRIDGING THERAPHY BEFORE ALLO-SCT IN B-ALL: 20-YEAR REAL-WORLD DATA

EHA Library, Jorge Nuñez Zuno, 4208056

CLINICAL OUTCOMES OF RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN PATIENTS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOLLOWING BLINATUMOMAB TREATMENT: CORBLIN-T

EHA Library, Akihito Shinohara, 4208057

EFFICACY AND TOXICITY OF INOTUZUMAB OZOGAMICIN BRIDGING TO CELLULAR THERAPIES IN A REAL-WORLD SETTING

EHA Library, Mohit Vijayakumar, 4208058

EVALUATION OF BONE METABOLISM PARAMETERS AND BONE MINERAL DENSITY IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA: A RETROSPECTIVE SINGLE-CENTER STUDY

EHA Library, Ugur Mete, 4208059

OUTCOMES OF ADOLESCENTS AND YOUNG ADULTS ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH THE PEDIATRIC EORTC 58951 PROTOCOL

EHA Library, Imen Frikha, 4208060

LABORATORY'S ROLE  IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)  IN A REAL WORLD SETTING. EXPERIENCE OF THE ALLIC 2010 PROTOCOL. GATLA GROUP

EHA Library, Tania Encina, 4208061

TARGETING RIBOSOMAL RNA 2′-O-METHYLATION SELECTIVELY IMPAIRS LEUKAEMIA STEM CELLS

EHA Library, Jia Yan, 4208062

CSN5I-3 TARGETING OF JAB1 DISRUPTS FLT3-ITD SIGNALING AND IMPAIRS LEUKEMIC PROGRESSION IN ACUTE MYELOID LEUKEMIA

EHA Library, Jian-Chuan Deng, 4208063

HPCAL1-PPIL2 INTERACTION DRIVES GLYCOLYSIS AND REPRESENTS A THERAPEUTIC TARGET IN AML

EHA Library, Linna Cheng, 4208064

ULTRA-HIGH-SENSITIVITY NEXT-GENERATION SEQUENCING–BASED MRD PREDICTS OUTCOME IN INTENSIVELY TREATED OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA: RESULTS FROM THE ALFA-1200 COHORT

EHA Library, Augustin Boudry, 4208065

ERADICATION OF LEUKEMIC STEM CELLS IN ACUTE MYELOID LEUKEMIA BY INDUCTION OF EXCESSIVE PRO-INFLAMMATORY SIGNALING RESULTS IN DEEP AND DURABLE REMISSION IN AML PDX MODELS

EHA Library, Philipp Jost, 4208066

MULTI-OMICS CLASSIFICATION OF ACUTE MYELOID LEUKEMIA GUIDES DRUG COMBINATIONS TO OVERCOME VENETOCLAX RESISTANCE

EHA Library, Runyu Yang, 4208067

CD96 AS A THERAPEUTIC TARGET FOR CAR T-CELL THERAPY IN ACUTE MYELOID LEUKEMIA

EHA Library, Xiaotong Gao, 4208068

FLT3-ITD REPROGRAMS LEUCINE ANABOLISM TO DRIVE ACUTE MYELOID LEUKEMIA PROGRESSION

EHA Library, Jun Long, 4208069

KMT2E/SWI-SNF-INDUCED CHROMATIN REMODELING ENHANCES TRANSFORMATION BUT ALSO ENABLES ATRA-INDUCED DIFFERENTIATION IN ACUTE MYELOID LEUKEMIA

EHA Library, Isabel Weinhäuser, 4208070

OVERCOMING THE UNDRUGGABLE: AN AI-DRIVEN DESIGN PEPTIDE INHIBITOR TARGETING THE TBK1-OPTN INTERACTION SUPPRESSES AML AND REVERSES VENETOCLAX RESISTANCE

EHA Library, Fan Niu, 4208071

DECODING THE IMMUNE GEOGRAPHY OF ACUTE MYELOID LEUKEMIA IN THE LUNG

EHA Library, Varvara Paraskevopoulou, 4208072

THE HOXA9/METTL3/BMI1 AXIS PROMOTES ANTHRACYCLINE RESISTANCE IN ACUTE MYELOID LEUKEMIA THROUGH MRNA M6A MODIFICATION OF BMI1

EHA Library, Hao Wang, 4208073